Reduction in cardiovascular risk using proactive multifactorial intervention versus usual care in younger (<65 years) and older (≥65 years) patients in the CRUCIAL trial

Author： Kim Jae-Hyung   Zamorano José   Erdine Serap   Pavia Abel   Al-Khadra Ayman   Sutradhar Santosh   Yunis Carla  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.29, Iss.5, 2013-05, pp. : 453-463

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolerability of solifenacin and oxybutynin immediate release in older (>65 years) and younger (≤65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study

By Herschorn S.   Pommerville P.   Stothers L.   Egerdie B.   Gajewski J.   Carlson K.   Radomski S.   Drutz H.   Schulz J.   Barkin J.   Hirshberg E.   Corcos J.  

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 375-382

Informa Healthcare

Access to resources Recommend Favorite

Effect of seasonality and weather on fracture risk in individuals 65 years and older

By Bischoff-Ferrari H.   Orav J.   Barrett J.   Baron J.  

Osteoporosis International, Vol. 18, Iss. 9, 2007-09 ,pp. : 1225-1233

Springer Publishing Company

Access to resources Recommend Favorite

Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance

By  

CANCER, Vol. 124, Iss. 4, 2018-02 ,pp. : 752-759

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients

By Athyros Vasilios G.   Katsiki Niki   Karagiannis Asterios  

Current Medical Research and Opinion, Vol. 29, Iss. 7, 2013-07 ,pp. : 791-792

Informa Healthcare

Access to resources Recommend Favorite

Post hoc analysis of the Cluster Randomized Usual Care versus Caduet Investigation Assessing Long-term risk (CRUCIAL) trial

By Hradec Jaromír  

Current Medical Research and Opinion, Vol. 29, Iss. 6, 2013-06 ,pp. : 589-596

Informa Healthcare

Access to resources Recommend Favorite